Nothing Special   »   [go: up one dir, main page]

MX2016013849A - Un factor de secrecion de proteinas con alta eficacia secretora y un vector de expresion que lo comprende. - Google Patents

Un factor de secrecion de proteinas con alta eficacia secretora y un vector de expresion que lo comprende.

Info

Publication number
MX2016013849A
MX2016013849A MX2016013849A MX2016013849A MX2016013849A MX 2016013849 A MX2016013849 A MX 2016013849A MX 2016013849 A MX2016013849 A MX 2016013849A MX 2016013849 A MX2016013849 A MX 2016013849A MX 2016013849 A MX2016013849 A MX 2016013849A
Authority
MX
Mexico
Prior art keywords
secretory
same
expression vector
protein
efficiency
Prior art date
Application number
MX2016013849A
Other languages
English (en)
Inventor
Chul Kim Yeon
Hae KIM Seung
Jung Saem
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Publication of MX2016013849A publication Critical patent/MX2016013849A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515—Complete light chain, i.e. VL + CL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a un nuevo factor de secreción de proteínas, a un vector que incluye una secuencia de ácidos nucleicos que codifica el factor de secreción de proteínas y a una célula transformada en la cual es introducido el vector. La invención también se refiere a un procedimiento para producir una proteína diana usando le célula transformada que incluye el vector.
MX2016013849A 2014-04-30 2015-04-30 Un factor de secrecion de proteinas con alta eficacia secretora y un vector de expresion que lo comprende. MX2016013849A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020140052752A KR102092225B1 (ko) 2014-04-30 2014-04-30 고효율 분비능을 가지는 단백질 분비 인자 및 이를 포함하는 발현 벡터
PCT/KR2015/004389 WO2015167278A1 (en) 2014-04-30 2015-04-30 A protein secretory factor with high secretory efficiency and an expression vector comprising the same

Publications (1)

Publication Number Publication Date
MX2016013849A true MX2016013849A (es) 2017-02-02

Family

ID=54358915

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016013849A MX2016013849A (es) 2014-04-30 2015-04-30 Un factor de secrecion de proteinas con alta eficacia secretora y un vector de expresion que lo comprende.
MX2020003508A MX2020003508A (es) 2014-04-30 2016-10-21 Un factor de secrecion de proteinas con alta eficacia secretora y un vector de expresion que lo comprende.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2020003508A MX2020003508A (es) 2014-04-30 2016-10-21 Un factor de secrecion de proteinas con alta eficacia secretora y un vector de expresion que lo comprende.

Country Status (10)

Country Link
US (3) US10407475B2 (es)
EP (1) EP3137493B1 (es)
JP (2) JP6471175B2 (es)
KR (1) KR102092225B1 (es)
CN (1) CN106255700B (es)
AR (1) AR100255A1 (es)
BR (1) BR112016024895A2 (es)
MX (2) MX2016013849A (es)
TW (1) TWI708780B (es)
WO (1) WO2015167278A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3700921A4 (en) 2017-10-27 2021-12-15 Pfenex Inc. PROCESS FOR THE PRODUCTION OF RECOMBINANT ERWINIA ASPARAGINASE
AU2018354068C1 (en) 2017-10-27 2023-03-23 Pelican Technology Holdings, Inc. Method for production of recombinant E. coli asparaginase
CN111372941A (zh) * 2017-10-27 2020-07-03 菲尼克斯公司 用于周质蛋白质表达的细菌前导序列
JP2021535746A (ja) 2018-09-05 2021-12-23 エルジー・ケム・リミテッド Ｏ−グリコシル化可能なポリペプチド領域を含む融合ポリペプチド
AU2019397511A1 (en) 2018-12-13 2021-07-22 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
JP7253773B2 (ja) * 2019-01-18 2023-04-07 株式会社大一商会 遊技機
JP7253771B2 (ja) * 2019-01-18 2023-04-07 株式会社大一商会 遊技機
JOP20210282A1 (ar) 2019-04-23 2023-01-30 Lg Chemical Ltd بولي ببتيد اندماج يتضمن منطقة fc لجلوبيولين مناعي وgdf15
MX2022006522A (es) 2019-12-02 2022-09-12 Lg Chemical Ltd Factores secretores de proteina derivados de celulas cho y vectores de expresion que comprenden los mismos.
KR20220138352A (ko) 2021-04-05 2022-10-12 주식회사 엘지화학 코로나바이러스 백신 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022847A (en) * 1997-03-19 2000-02-08 Zymogenetics, Inc. Secreted salivary zsig32 polypeptides
AU764441B2 (en) * 1998-02-09 2003-08-21 Genset S.A. cDNAs encoding secreted proteins
US6365369B1 (en) * 1998-04-01 2002-04-02 Human Genome Sciences, Inc. Prostate specific secreted protein
US7339033B2 (en) * 1998-06-26 2008-03-04 Genentech, Inc. Pro1481
EP1666594A3 (en) * 2000-06-02 2006-06-21 Genentech, Inc. Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer
KR20030062854A (ko) * 2002-01-21 2003-07-28 주식회사 엘지생명과학 분비형 벡터를 이용한 효모에서의 재조합 단백질의 제조방법
US7317091B2 (en) * 2002-03-01 2008-01-08 Xencor, Inc. Optimized Fc variants
WO2004094589A2 (en) 2003-04-18 2004-11-04 Incyte Corporation Secreted proteins
KR20070009269A (ko) * 2005-07-15 2007-01-18 한국생명공학연구원 재조합단백질 생산용 단백질융합인자 라이브러리 및이로부터 획득된 단백질융합인자
JP2007209328A (ja) * 2006-01-13 2007-08-23 Galpharma Co Ltd ガレクチン−９利用遺伝子治療剤
KR100954322B1 (ko) * 2006-06-14 2010-04-21 주식회사 엘지생명과학 췌장암과 관련된 신규한 ｌｂｆｌ313 유전자
CN1903876B (zh) * 2006-07-10 2010-09-01 郑鸿 一种多肽、编码它的核酸分子及用途
JP5812418B2 (ja) * 2009-04-17 2015-11-11 イムナス・ファーマ株式会社 Ａβオリゴマーに特異的に結合する抗体およびその利用
KR101868139B1 (ko) 2010-11-30 2018-06-15 주식회사 엘지화학 새로운 융합 프로모터 및 이를 포함하는 재조합 벡터
US9192651B2 (en) * 2012-04-02 2015-11-24 Moderna Therapeutics, Inc. Modified polynucleotides for the production of secreted proteins
EP2906599B1 (en) 2012-10-12 2019-07-17 Agency For Science, Technology And Research Optimised heavy chain and light chain signal peptides for the production of recombinant antibody therapeutics

Also Published As

Publication number Publication date
CN106255700A (zh) 2016-12-21
CN106255700B (zh) 2021-06-18
EP3137493A4 (en) 2017-11-15
EP3137493B1 (en) 2019-09-04
US20170044224A1 (en) 2017-02-16
JP2019006823A (ja) 2019-01-17
JP2017513511A (ja) 2017-06-01
US20230212236A1 (en) 2023-07-06
TWI708780B (zh) 2020-11-01
EP3137493A1 (en) 2017-03-08
KR102092225B1 (ko) 2020-03-23
AR100255A1 (es) 2016-09-21
JP6471175B2 (ja) 2019-02-13
US10407475B2 (en) 2019-09-10
KR20150125402A (ko) 2015-11-09
TW201625665A (zh) 2016-07-16
MX2020003508A (es) 2020-07-22
US20200255485A1 (en) 2020-08-13
BR112016024895A2 (pt) 2017-10-24
WO2015167278A1 (en) 2015-11-05

Similar Documents

Publication Publication Date Title
MX2020003508A (es) Un factor de secrecion de proteinas con alta eficacia secretora y un vector de expresion que lo comprende.
EP3741849A3 (en) Protease variants and polynucleotides encoding same
MX2017014125A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
MX2021007070A (es) Mutantes de proteina f de rsv.
MX2023011785A (es) Metodos y composiciones para produccion de proteina de clara de huevo.
MX2017003847A (es) Proteinas biespecificas activables por proteasas.
PH12018502456A1 (en) Anti-cd04 antibodies and their uses
MX2017007731A (es) Composiciones de detergente, variantes de lipasa y polinucleotidos que codifican las mismas.
EP3741848A3 (en) Protease variants and polynucleotides encoding same
WO2016066756A3 (en) Protease variants and polynucleotides encoding same
WO2016066757A3 (en) Protease variants and polynucleotides encoding same
BR112018010429A2 (pt) ácidos nucleicos que se direcionam a ácidos nucleicos engenheirados
MX2019005158A (es) Variantes de glucoamilasa y polinucleotidos que las codifican.
MX2022001085A (es) Anticuerpos anti-c1s humanizados y metodos para usarlos.
MY192824A (en) Compound targeting il-23a and tnf-alpha and uses thereof
MY180732A (en) Protein manufacture
MX2018011980A (es) 3-epimerasa y polinucleotido que la codifica.
EA201990758A1 (ru) Способ получения электрокомпетентных дрожжевых клеток и способ применения указанных клеток
MY183321A (en) Microorganism producing o-acetyl-homoserine and method for producing o-acetylhomoserine using the same
MY183061A (en) Polypeptides having xylanase activity with a high conversion rate of xylose-containing polysaccharides
EP3140392C0 (en) PRODUCTION OF HETEROMULTIMERIC PROTEINS BY MEANS OF MAMMALIAN CELLS
MX2020002329A (es) Terpeno sintasa que produce patchulol y elemol, y preferiblemente tambien pogostol.
MY182443A (en) Method of producing lipid
MY184391A (en) Microorganism having improved intracellular energy level and method for producing l-amino acid using same
EP3739045A3 (en) Cellobiohydrolase variants and polynucleotides encoding same